Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, 100-count bottles, Rx only, Mfg for:...

FDA Drug Recall #D-0532-2025 — Class II — June 20, 2025

Recall Summary

Recall Number D-0532-2025
Classification Class II — Moderate risk
Date Initiated June 20, 2025
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Lupin Pharmaceuticals Inc.
Location Naples, FL
Product Type Drugs
Quantity 58,968 bottles

Product Description

Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, 100-count bottles, Rx only, Mfg for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, Manufactured by: Lupin Limited Nagpur-441 108, INDIA, NDC 68180-519-01

Reason for Recall

Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg.

Distribution Pattern

Product was distributed nationwide within the United States.

Lot / Code Information

Lot #: QA01081, Exp. Date April 2027

Other Recalls from Lupin Pharmaceuticals Inc.

Recall # Classification Product Date
D-0541-2026 Class II Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx... Apr 24, 2026
D-0220-2026 Class II Ganirelix Acetate Injection, 250 mcg/0.5mL, Sin... Nov 13, 2025
D-0227-2026 Class II Sertraline Hydrochloride Tablets USP, 100 mg, 9... Nov 5, 2025
D-0542-2025 Class II Amlodipine and Benazepril HCl Capsules USP 2.5 ... Jul 2, 2025
D-0537-2025 Class II clomiPRAMINE Hydrochloride Capsules USP 25 mg, ... Jun 27, 2025

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.